- AMLX -1.37%
Search results
- 2.8800Add to watchlist-0.0400 (-1.37%)At close:4:00 PM EDTWed. Sep 18, 20242.9500 +0.07 (+2.43%)Pre mkt:8:42 AM EDTThu. Sep 19, 2024Nasdaq Real Time Price (USD) · Pre-Market Time
- Open2.9200High2.9650Low2.8250
- Mkt Cap196.08MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close2.920052 Wk. Low1.575052 Wk. High19.9490
Top storiesDirector MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)Yahoo Finance · 2 weeks ago- AMLX -1.37%
Actimed’s ALS candidate wins FDA orphan drug designationYahoo Finance · 2 weeks agoRelated stocks
AMLX is a biotech company developing treatments for ALS and other neurodegenerative diseases. See its latest stock price, performance, news, earnings, and compare it with other biotech stocks.
- Chart
Interactive Chart for Amylyx Pharmaceuticals, Inc. (AMLX),...
- Profile
See the company profile for Amylyx Pharmaceuticals, Inc....
- Analysis
See Amylyx Pharmaceuticals, Inc. (AMLX) stock analyst...
- Statistics
Find out all the key statistics for Amylyx Pharmaceuticals,...
- Historical Data
Discover historical prices for AMLX stock on Yahoo Finance....
- Sustainability
See Amylyx Pharmaceuticals, Inc. (AMLX) Environment, Social...
- Chart
1 day ago · AMLX is the ticker symbol for Amylyx Pharmaceuticals Inc., a biotech company developing treatments for amyotrophic lateral sclerosis (ALS). The stock price, performance, news, analyst ratings and recent events of AMLX are shown on this page.
People also ask
What is the target price for amylyx pharmaceuticals (amlx) stock?
What does amlx stand for?
What are amlx share price targets?
Who is amylyx pharmaceuticals?
AMLX is a biopharmaceutical company developing a therapy for ALS. See its latest financial results, market news, and stock performance on Google Finance.
3 days ago · View Amylyx Pharmaceuticals, Inc AMLX investment & stock information. Get the latest Amylyx Pharmaceuticals, Inc AMLX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
AMLX is a biopharmaceutical company developing disease-modifying solutions for neurodegenerative diseases. See its current price, daily change, revenue, gross margin, market cap, and more financial data and analysis.
- Amylyx Pharmaceuticals
5 days ago · AMLX is a biotech company developing drugs for ALS and other neurodegenerative diseases. See the latest stock price, news, financials, statistics, forecast, dividends, profile and chart of AMLX on Stock Analysis.
Is Amylyx (AMLX) Stock a Solid Choice Right Now? Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS).